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Dysregulation of growth factors and their receptors is central to human hepatocellular carcinoma (HCC). We previously
demonstrated that the Frizzled-7 membrane receptor mediating the Wnt signalling can activate the b-catenin pathway and promotes
malignancy in human hepatitis B virus-related HCCs. Expression patterns of all the 10 Frizzled receptors, and their extracellular
soluble autoparacrine regulators (19 Wnt activators and 4 sFRP inhibitors) were assessed by real-time RT–PCR in 62 human HCC of
different etiologies and their matched peritumorous areas. Immunostaining was performed to localise Frizzled on cell types in liver
tissues. Regulation of three known Frizzled-dependent pathways (b-catenin, protein kinase C, and C-Jun NH2-terminal kinase) was
measured in tissues by western blot. We found that eight Frizzled-potentially activating events were pleiotropically dysregulated in
95% HCC and 68% peritumours as compared to normal livers (upregulations of Frizzled-3/6/7 and Wnt3/4/5a, or downregulation of
sFRP1/5), accumulating gradually with severity of fibrosis in peritumours and loss of differentiation status in tumours. The hepatocytes
supported the Wnt/Frizzled signalling since specifically overexpressing Frizzled receptors in liver tissues. Dysregulation of the eight
Frizzled-potentially activating events was associated with differential activation of the three known Frizzled-dependent pathways. This
study provides an extensive analysis of the Wnt/Frizzled receptor elements and reveals that the dysregulation may be one of the
most common and earliest events described thus far during hepatocarcinogenesis.
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Hepatocellular carcinoma (HCC) is one of the most frequent
tumours worldwide. It develops mostly in cirrhotic livers, whose
risk factors include chronic infection by hepatitis B and C viruses
(HBV and HCV), and nonviral liver diseases (Llovet et al, 2003;
Bosch et al, 2005). Unfortunately, cellular mechanisms of
hepatocarcinogenesis remain poorly understood. Initially, a variety
of genetic and epigenetic alterations were detected in HCCs and to
a lesser extent in preneoplastic cirrhotic livers. Later on, DNA
microarray analysis led to an extensive integrative approach,
leading to the identification of clusters of HCCs associated with
patterns of gene expression that allow comparison between HCC
phenotypes in experimental and human HCCs (Lee and
Thorgeirsson, 2006). In parallel, recent progress has been achieved
in understanding the essential role and function that represents
dysregulation of pleiotropic growth factors – that is, the insulin-
like growth factor-II (IGF-II), hepatocyte growth factor (HGF),
transforming growth factor-a (TGF-a), transforming growth
factor-b (TGF-b), and wingless (Wnt) – in contributing to
proliferation and antiapoptotic behaviour of HCC cells (Breuhahn
et al, 2006).
Concerning the Wnt signalling cascade, the binding of one
among the 19 known extracellular soluble secreted Wnt ligands
(WNT) to one or more among the 10 Frizzled receptors (FZD) in
cooperation or not with LRP coreceptors (low-density lipoprotein
receptor (LDLR)-related protein), LRP-5 or LRP-6, can differen-
tially lead to the activation of either the canonical b-catenin, or the
noncanonical c-Jun N-terminal kinase (JNK) and protein kinase C
(PKC) pathways, which may control the tumour phenotype. In
contrast, four sFRP (secreted Frizzled-related proteins), which are
extracellular soluble factors, can bind WNT and thereby down-
regulate their ability to activate FZD (Jones and Jomary, 2002).
Different studies have clearly shown the upregulation of WNT/FZD
elements in different types of cancers, highlighting their direct role
in carcinogenesis as witnessed by the activation of oncogenic
pathways and control of the cancerous phenotype (Tanaka et al,
1998; Kirikoshi et al, 2001; Holcombe et al, 2002; Weeraratna et al,
2002; Qiang et al, 2003; Lu et al, 2004; Zeng ZY et al, 2007).
However, the expression patterns of all the WNT/FZD family
members have not been extensively evaluated in human HCC
so far.
We have previously shown the activation of b-catenin by
overexpression of FZD7 in human HBV-related HCCs as well as
in several transgenic mouse models of hepatocarcinogenesis
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s(Merle et al, 2004; Merle et al, 2005). Additionally, we have shown
that FZD7 can be activated in vitro by binding of the WNT3 ligand
(Kim et al, 2008). In this study, the expression patterns of all 19
WNT,1 0FZD, two LRP, and four sFRP genes have been
determined in HCCs and in their matched surrounding
precancerous peritumorous areas, by comparison to normal liver
(NL) tissues. This revealed that three different FZD (FZD3, 6, and
7) are commonly upregulated in HCC cells, in association with the
activation of potentially FZD-dependent cascades such as the
canonical b-catenin, as well as the noncanonical PKC and JNK
pathways. Furthermore, these three receptors were overexpressed
concomitantly with either upregulation of three Wnt agonists
(WNT3, 4, and 5A) or downregulation of two Wnt antagonists
(sFRP1 and 5). We propose that accumulation of these events is
independent of aetiologic factors, correlates more closely with
progression from cirrhosis to HCC and ultimately directly relates
to the loss of differentiation of such tumours. In parallel, we have
shown that the WNT/FZD/sFRP expression patterns did not
correlate to the TP53 and b-catenin gene mutation status in the
HCC samples, these genes being the most frequently altered
tumour suppressor and proto-oncogene in HCC (Laurent-Puig and
Zucman-Rossi, 2006).
MATERIALS AND METHODS
Human liver tissues
Sixty two frozen HCCs surgically resected from different individuals
were obtained from Thailand (International Agency for Research on
Cancer) (n¼10) and France (National Resource Biological Center)
(n¼52), a written consent being obtained before surgery. Tissue
samples were obtained and characterized as tumorous (T) or
matched peritumorous liver parenchymas (pT). NL came from
parenchyma surrounding surgically resected focal nodular hyper-
plasia from different individuals (n¼9). HCCs were due to HBV
(n¼18) or HCV (n¼20) infection as defined by positivity for HBs
antigen or anti-HCV antibodies in serum, respectively, whereas
others were presumed as nonviral-related (NBNC) tumours (n¼24).
Histological analysis
Histological analysis was performed on T to confirm the diagnosis
of HCC and to classify them as to their differentiation status.
Furthermore, histology served on pT as a method of assessing
fibrosis stage using the Metavir criteria (The French METAVIR
Cooperative Study Group, 1994), and to further ensure the absence
of microscopic tumour invasion.
Cell lines
The human HCC cell lines Huh7, Focus, PLC/PRF/5, Hep3B, as well
as the hepatoblastoma HepG2 cell line, were grown in DMEM F-12,
1X-MEM nonessential amino-acid solution, 200mML -glutamine,
1 -sodium-pyruvate, 1% (vol/vol) penicillin/streptomycin
(Invitrogen), and supplemented with 10% (vol/vol) fetal calf
serum (Sigma). Human primary hepatocytes were cultured in
HCM Bullet-kit hepatocytes culture medium (Cambrex).
Semi-quantitative real-time RT–PCR
We assessed the expression of the 19 WNT,4sFRP,1 0FZD and 2
LRP genes in cell lines, and liver tissues (62 T and 62 pT) as
determined by an arbitrary value (AV) Additionally, a cohort of
nine NL served as controls which gave cutoff values equal to
mean±2 s.d. (a¼0.05) for upregulation or downregulation of the
different genes in pT and T. Total RNA extractions as well as cDNA
synthesis were prepared as described previously (Merle et al,
2004). PCR reactions were performed by 35 cycles (951C1 5s ,6 0 1C
1min) using the MyIQt Real Time PCR Detection System
(Bio-Rad) with a mix composed of 1X-Quantitech Sybr Green
PCR Kit (Qiagen), primers at either 500nM (Wnt, sFRP, FZD, and
LRP) or 800nM (18S RNA), and 12.5ng cDNA (equivalent total
RNA) from unknown samples. Each PCR run included the
unknown cDNAs and a nontemplate control (RNA sample treated
with DNase without RT step) to check for the absence of genomic
DNA contamination. Regarding the specificity of reactions, melt
curves were analysed for each sample and the corresponding PCR
products of the positive controls were cloned into the pCR
s
2.1 Vector (Invitrogen, Life Technology) and sequenced. Primers
for sFRP genes were selected using the previously described
strategy (Merle et al, 2004). Primers for FZD7 and 18SrRNA were
previously published (Merle et al, 2004), as well as those for Wnt,
FZD (except FZD7), and LRP (Lu et al, 2004) with slight
modifications to obtain identical annealing temperature and PCR
amplification efficiency as for FZD7, 18S rRNA, and sFRP primers
(Supplementary online data no. 1). The amount of specific mRNA
was quantified in unknown samples by using the comparative Ct
method: the DCt values from each tissue were obtained by
subtracting the values for 18S Ct from the Ct of each tested gene.
One difference in DCt represents a two-fold difference in the level
of mRNA as described in (Lu et al, 2004), this method is giving an
AV for the expression of each gene per tissue.
Immunostaining
Immunohistochemistry was used to localise FZD3/6/7 in T and pT
tissues fixed in 10% neutral-buffered formalin and embedded in
paraffin. After antigen unmasking by heating slices in a microwave
oven in citrate buffer at pH 6.0 for 10min, the 5mm sections were
incubated overnight at 41C with anti-FZD3 (1/150, LifeSpan,
Biosciences, LS-A4454), anti-FZD6 (1/70, LifeSpan, Biosciences,
LS-A4481) or anti-FZD7 (1/200, Sigma, F3679) rabbit polyclonal
antibodies. Endogenous peroxidase activity was blocked with the
Peroxidase-Blocking reagent (DakoCytomation) for 10min and
nonspecific antibody binding was blocked with 10% skimmed milk
for 30min at 201C. The Antibody-Diluent reagent (DakoCytoma-
tion) served as a negative control under equivalent conditions in
place of the primary antibody. A goat antirabbit IgG conjugated to
peroxidase-labelled polymers diluted in Tris-HCl buffer
(EnVisionþ Dual Link System Peroxidase – DakoCytomation)
was added according to the manufacturer’s instructions. For
amplification of the reaction, a soluble antigen–antibody of
horseradish peroxidase antiperoxidase developed in the rabbit
(Sigma) was used at 1/200 dilution for 30min at 201C. Colorimetric
reaction was developed with 3,30-diaminobenzidine (Liquid
DABþ Substrate Chromogen System- DakoCytomation) for
2min. Slides were counterstained with Harris hematoxylin,
dehydrated, and coverslipped with EUKITT (O Kindler GmbH
& CO, Freiburg).
Protein extraction and western blotting
We analysed by western-blotting the activaty status of the three
FZD-dependent intracellular pathways – that is, b-catenin, PKC,
JNK – in T showing overexpressing of FZD3, 6, and/or 7 by
comparison with their matched pT. Samples were treated with
200ml of extraction buffer (30mM Tris-pH 7.5, 150mM NaCl, 1%
NP-40, 0.5% Na deoxycholate, 0.1% SDS, 10% glycerol and 2mM
EDTA) containing protease inhibitors and phosphatase inhibitors
(Roche Diagnostics). Protein concentration was determined with
the BCA Protein Assay Kit (Pierce) using BSA as standard.
Subcellular fractionations were performed as described previously
(Maloney et al, 1998), and protein concentration was measured by
the method of Bradford with the Bio-Rad Protein Assay Kit
(Bio-Rad Laboratories, Hercules, USA) using BSA as standard.
Aliquot of proteins were resolved on SDS–PAGE and transferred
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membranes were blocked with 5% nonfat dry milk in Tris-
buffered saline containing 0.1% Tween 20, and then probed with
an antibody targeting total b-catenin (Transduction Laboratory) or
phospho-Thr41/Ser45 b-catenin (Cell Signalling), pan-PKC (Santa
Cruz Technology) or pan-phospho-PKC (Cell Signalling), JNK
(R&D Systems) or phospho-JNK (R&D Systems). The corresponding
horseradish peroxidase antibodies were incubated and revealed
with the chemiluminescence imaging ECL (Sigma). All of the blots
were standardized for equal protein loading by Red Ponceau
staining and western blotting for b-actin (Sigma).
PCR/DHPLC Sequencing of CTNNB1 and TP53 Genes
For denaturing high performance liquid chromatography
(DHPLC) analysis, crude amplification products were denaturated
by heating at 951C then cooled to 251C over 1h. DHPLC analysis
were performed by injecting 5–8ml of PCR products into a
preheated reverse-phase column (DNASep Column, Transge-
nomic) equilibrated with an ion pairing agent TEAA 0.1 M
(Triethylammonium acetate). DNA was removed from the column
by a linear gradient of eluting buffer containing 25% acetonitrile at
a constant flow rate of 0.9mlmin
 1 and with 2% per min gradient
increase. Transgenomic UV-detector identified the eluted DNA at
260nm. All amplimers with different profile shapes or retention
times were sequenced to confirm the putative sequence variations.
Concerning PCR sequencing, primer pairs were designed for
amplification of exons-4 to -9 for TP53, and exon-3 for b-catenin
genes (Supplementary online data no. 2). Each PCR mix contained
genomic DNA, 1.5mM MgCl2, 0.2mM each dNTP, 0.4mM each
primer, 1X-PCR Buffer (Invitrogen) and 2U Platinum
s Taq DNA
Polymerase (Invitrogen) for a final reaction volume of 50ml. The
PCR amplification for TP53 exons was performed using the
following conditions: initial denaturation at 941C 2min, 20 cycles
(941C4 5 s ,6 3 1C 30s, and gradual decrease of 0.51C per three
cycles, 721C 45s) followed by 30 cycles (941C4 5s ,6 0 1C 30s, and
721C 45s) and ending with an extension at 721C 10min. The
cycling profile for b-catenin exon-3 amplification was the
following: initial denaturation at 951C 2min, 20 cycles (951C3 0s ,
561C 30s, and gradual decrease of 0.41C per two cycles, 721C3 0s )
followed by 30 cycles (951C3 0 s ,5 2 1C 30s, and 721C 30s) and
ending with extension at 721C 7min.
Statistical analysis
The Mann–Whitney U-test was used with StatView software
Version 5.0 (SAS Institute Inc.), and w
2test when necessary. Tests
were considered significant when their P values were o0.05.
RESULTS
Expression patterns of FZD, LRP, WNT, and sFRP genes at
the mRNA level in liver tissues by quantitative real-time
RT–PCR
Three different FZD genes were found frequently upregulated in T
and pT by comparison to NL (4cut-off; Figure 1): FZD3 (41% T,
23% pT), FZD6 (31% T, 8% pT), and FZD7 (33% T, 10% pT). By
contrast, almost none of the samples showed any significant
upregulation or downregulation of LRP genes in pT or T tissues by
comparison to NL (o or 4cut-off). Concerning the soluble
extracellular regulators of the Frizzled membrane receptors,
WNT3, WNT4, and WNT5A, potent activators, were strikingly
found upregulated by comparison to NL (4cutoff value): WNT3
(39% T, 25% pT), WNT4 (20% T, 16% pT), and WNT5A (25% T,
7% pT). Among the potential inhibitors of the Frizzled receptors,
two sFRP genes were found downregulated: sFRP1 (53% T, 21%
pT), and sFRP5 (28% T, 12% pT).
Taken together, these results demonstrated that when pooling
the eight following events – that is, upregulation of potential
activators (FZD3, FZD6, FZD7, WNT3, WNT4, and WNT5A)o r
repression of inhibitors (sFRP1 and sFRP5) of the WNT/FZD
signalling – one of them at least occurred in 68% pT and 95% T.
Strikingly, each of these events accumulated with progression from
noncirrhotic to cirrhotic tissues of peritumour areas (0.6±0.6
events per noncirrhotic pT vs 1.4±0.9 events per cirrhotic pT;
Po0.01). They additionally carried on their accumulation within
tumours (1.4±0.9 events per cirrhotic pT vs 2.1±0.9 per well-
differentiated HCC, Po0.05), and subsequently with the loss of
differentiation status of tumours (2.1 ±0.9 per well-differentiated
HCC vs 3.0±1.3 events per moderately to poorly differentiated
tumour; Po0.05) (Figure 2).
It is of note that, we carefully evaluated by serial tissue sections
that none of the pT with elevated WNT/FZD or decreased sFRP
expression levels had microscopic HCC tumour foci. Concerning
relationship to aetiologic factors of HCC, with the notable
exception of FZD7 which showed higher rate of upregulation in
HBVvs non-HBV-related HCC (59 vs 23%, CHI-2 test, P¼0.035),
WNT3/4/5A, FZD3/6, and sFRP1/5 were statistically equally
dysregulated between HBV, HCV, and NBNC-related HCCs.
Correlation of WNT/FZD/sFRP expression to mutation
status of b-Catenin and TP53 genes in HCCs
The b-catenin and TP53 mutation status was determined in HCC
and compared to WNT/FZD/sFRP expression patterns (Supple-
mentary online data no. 3). The b-catenin gene was found mutated
mainly in HCV-related HCC (HBV 17%, HCV 40%, and NBNC
21%), whereas TP53 mutations did not correlate with aetiologic
factors (HBV 33%, HCV 30%, and NBNC 13%). There was no
correlation between these mutations and a specific WNT/FZD/sFRP
expression pattern in HCC.
Cell specificity of Frizzled receptors and activity of
Frizzled-dependent intracellular pathways
Immunostaining allowed at identifying the specific cells, which
overexpressed FZD3, FZD6, and FZD7 proteins within T and pT
tissues. As shown in Figure 3, these three receptors were highly
expressed by HCC cells in T, and at a lesser extent by
nontransformed hepatocytes in pT, whereas they were barely or
not expressed by both nonhepatocytic cells and normal hepato-
cytes in NL. As a confirmatory result, quantitative real-time RT–
PCR data showed the capability of cancerous HCC cell lines to
express high steady state levels of FZD3, FZD6, and/or FZD7
mRNAs, whereas normal primary hepatocytes did not (Table 1).
Next, we assessed the activation of the downstream pathways
potentially controlled by the WNT/FZD signalling – that is,
b-catenin, PKC and JNK – in liver tissues. To this aim, we
examined a cohort of 15 paired samples (T þ pT) where the
previously identified WNT3/4/5A, FZD3/6/7, sFRP1/5 events
gradually accumulated from pT towards the matched T, each pT
serving as a matched negative control for the corresponding T. As
expected, most of the tested T (13/15, 87%) showed higher activity
of either b-catenin, PKC or JNK pathways than their matched pT
(Table 2), as shown respectively by unphosphorylation of the
cytosolic form of b-catenin at threonine-41/serine-45 residues,
phosphorylation of PKC at serine-660 residue, and phosphoryla-
tion of JNK at threonine-183/tyrosine-185 residues (Figure 4).
Before assessing the potential impact of the WNT/FZD signalling
on the activity of b-catenin, we carefully checked that all tested T
samples did not contain specific mutations within the serine/
threonine residues of the b-catenin gene. In contrast, 3/4 (75%) T
devoided of accumulation of WNT/FZD events did not show
increased activity of one of the three pathways in T vs pT (Table 2).
Wnt/Frizzled in hepatocellular carcinoma
A Bengochea et al
145
British Journal of Cancer (2008) 99(1), 143–150 & 2008 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sDISCUSSION
We have demonstrated for the first time that dysregulation of the
WNT/FZD receptor elements is an overall common feature in
human hepatocarcinogenesis. This study has provided a compre-
hensive transcriptomic analysis of the FZD/LRP receptor com-
plexes, and some of their potential autoparacrine regulators – that
is, WNT and sFRP elements in human HCC. We have identified
eight potential FZD activating events, each occurring in a
significant proportion of HCCs (X20%) – that is, upregulation
of FZD3/6/7 and WNT3/4/5A, and repression of sFRP1/sFRP5 –
which accumulate with severity of the liver disease and tumour
stage. Furthermore, we have shown that the FZD3/6/7-mediated
signalling is supported by HCC cells within tumour liver tissues.
Finally, we have observed that at least one over the three known
different intracellular pathways potentially controlled by the
WNT/FZD signalling during embryogenesis or carcinogenesis –
that is, canonical b-catenin, or noncanonical PKC and
JNK – appeared activated in a majority of the tested HCC tissues
containing the accumulation of WNT/FZD element dysregulations.
Research on dysregulation of growth factors and their receptors
aims at establishing the role and function of the corresponding
signalling cascades in human hepatocarcinogenesis towards the
identification of new therapeutic targets. In this view, we
previously demonstrated the activation of the WNT/FZD signalling
through FZD7 overexpression in transgenic mouse models of HCC
as well as in human HBV-related HCC tissues from Taiwan and
South Africa (Merle et al, 2004, 2005). However, it remained
questionable whether FZD7, among the ten known human FZD
receptors, is the unique FZD involved in human hepatocarcino-
genesis, and what happened in non-HBV-related HCCs. In this
study, we have confirmed in tissues from Thailand and Western
Europe that FZD7 is overexpressed in a majority of HBV-related
HCCs and, although at a lesser extent, in a significant proportion
of HCV and nonvirus-related HCCs. At present, no information is
available as to the possible interactions between HBV and the
regulatory elements of FZD7, thus emphasising the need for
additional investigation. Furthermore, we have shown that not
only FZD7 but also FZD3 and FZD6 are commonly overexpressed
in HCCs. Noticeably, FZD3, and FZD7 were found more closely
related to the poorly differentiation status of tumours, indicating
their possible involvement in the latter steps of hepatocarcino-
genesis, and their possible role in the metastasis processes and
epithelial-mesenchymal transition as recently reported for FZD7 in
A
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Figure 1 Expression patterns of FZD/LRP/WNT/sFRP genes in HCC tissues in T (A) and pT (B), by comparison to cutoff values obtained from NL. Each
line represents a different HCC tissue depending on the aetiologic factor (lines 1–18 for HBV, lines 19–38 for HCV, and lines 39–42 for NBNC).
Upregulation of genes are indicated in coloured boxes as light blue (one- to five-fold), medium dark blue (five- to 10-fold), or dark blue (410-fold).
Downregulation of genes are indicated in pink (five-fold), orange (five- to 10-fold), or brown (o10-fold).
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scolon tumours (Vincan et al, 2005). The potent soluble activators
of FZD3/6/7 are very likely those ligands to be found overexpressed
in HCCs (WNT3/4/5A).
These data correlate with FZD3/6 and WNT3 found over-
expressed in other malignancies as leukaemia, FZD7 in solid
tumours like nasopharynx, oesophagus, and stomach carcinomas,
WNT5A in leukaemia, melanoma, and nasopharynx carcinoma
(Tanaka et al, 1998; Kirikoshi et al, 2001; Holcombe et al, 2002;
Weeraratna et al, 2002; Qiang et al, 2003; Lu et al, 2004; Zeng ZY
et al, 2007), whereas WNT4 has been previously found over-
expressed in pancreatic cancers (Pasca di Magliano et al, 2007).
Concerning the soluble activators of FZD, previous studies have
shown the common downregulation of sFRP1 due to promoter
hypermethylation in HCC as well as in colon cancer (Suzuki et al,
2004; Shih et al, 2006, 2007). In this study, we have found that
although sFRP1 was commonly downregulated in pT and T,
another inhibitor such as sFRP5 shared the same expression
pattern of repression. Finally, as the WNT/FZD/sFRP signalling
elements are dysregulated in most HCCs, we have been unable to
find a specific association between their expression pattern and the
occurrence of either TP53 or b-catenin gene mutations, which
paradoxically had been shown in previous studies as dichotomizing
HCC tumours in different clusters (Laurent-Puig et al, 2001).
Of interest was the progressive accumulation of the FZD
activating events (WNT3/4/5A and FZD3/6/7 upregulations and
sFRP1/5 repression) with severity of the liver disease and the
tumour stage. These results suggest that the FZD activating event
accumulation may contribute to enhance the activity of the
downstream pathways that may control the cancerous phenotype.
Thus, we tried to assess the differential activity of the various
potentially FZD-dependent intracellular pathways (b-catenin, PKC,
and JNK) between HCC tumours (T) and their matched
nontumorous tissues (pT). The canonical WNT signals are
transduced through FZD family receptors and LRP5/LRP6
coreceptor to the b-catenin signalling cascade. In the absence of
canonical WNT signalling, b–catenin combined to APC and AXIN
is phosphorylated by casein kinase Ia (CKIa) and glycogen
synthase kinase 3b (GSK3 b), and polyubiquitinated by hTRCP1
or hTRCP2 for degradation by the proteasome. In the presence of
canonical WNT signalling, Dishevelled (DVL) is phosphorylated
by CKIa and complexes with FZD. Subsequently, b-catenin is
released from phosphorylation by CKIa and GSK3b for stabilisation,
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Figure 2 Evidence of accumulating WNT/FZD events with occurrence
of cirrhosis in peritumorous tissues, with development of tumours and
subsequently with severity of tumours in terms of dedifferentiation status.
Bars (±s.d.) represent the average number of events – that is, upregulation
of FZD3, FZD6, FZD7, WNT3, WNT4, and WNT5A or downregulation of
sFRP1, sFRP5 – per tissue sample. Comparisons were statistically assessed
by the Mann–Whitney U-test : *Po0.01 between noncirrhotic and
cirrhotic peritumours; **Po0.05 between cirrhotic peritumours and well-
differentiated tumours; ***Po0.05 between well-differentiated and
moderately/poorly differentiated tumours.
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Figure 3 Representative examples of immunostaining for Frizzled
receptors (FZD) in liver sections involving both T and pT: FZD3
(A), FZD6 (C) and FZD7 (E). Staining of NL is presented for comparison
for (B, D, and F). FZD3 was detected mainly in HCC cells as compared to
adjacent nontumorous hepatocytes (A). In the normal liver, only a faint
labelling was observed in the perivenous area of the lobule (B). FZD6 was
strongly expressed mainly in HCC cells as compared to adjacent
nontumorous hepatocytes (C). In the normal liver, no expression was
detected either in hepatocytes or normal biliary epithelial cells (D). FZD7
was highly expressed by HCC cells in a well-differentiated HCC (E). In the
normal liver, faint labelling was observed in hepatocytes located in the
perivenous region of the lobule (F). Size bars¼500mm.
Table 1 Steady state levels of mRNAs for FZD3, FZD6, and FZD7 genes
as assessed by quantitative real-time RT–PCR in different human
hepatoma cell lines in comparison to normal human primary hepatocytes
Hepatocytes FZD3 FZD6 FZD7
Normal primary hepatocytes +/  ++ /  
Hepatoma HepG2 ++ ++++ +/ 
Hepatoma Hep3B + +++++ +
Hepatoma PLC/PRF/5 ++ + ++
Hepatoma Focus ++ ++++ ++
Hepatoma Huh7 ++ + +++
As described in Material and Methods, any gene mRNA steady state level was
expressed as arbitrary value (AV). A semi-quantitative scale was proposed for gene
expression: ( ): AV¼0; (+/ ): AV¼0 to 20; (+): AV¼21 to 50; (++): AV¼51 to
100; (+++): AV¼101 to 150; (++++): AV¼151 to 200; (+++++): AV 4 200.
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b-catenin is complexed with T-cell factor/lymphoid enhancer
factor (TCF/LEF) family transcription factors and other proteins
(BCL9 and BCL9L Legless family docking proteins, and the PYGO1
and PYGO2 PYGO-family coactivators). The TCF/LEF-b-catenin-
Legless-PYGO nuclear complex is the effector of the canonical
WNT signalling pathway to activate the transcription of target
genes such as FGF20, DKK1, WISP1, MYC, and CCND1.
Noncanonical WNT signals are transduced through FZD family
receptors and coreceptors, such as ROR2 and RYK. Small G
proteins (RHOA, RHOU, RAC, and CDC42) and c-jun NH2-
terminal kinase are the DVL-dependent effector molecules of the
noncanonical pathway, whereas nemo-like kinase (NLK) and
nuclear factor of activated T cells (NFAT) are the Ca2þ-
dependent effector molecules of noncanonical pathway. Small G
proteins are implicated in the cytoskeletal reorganisation during
invasion and metastasis. NLK phosphorylates TCF/LEF family
transcription factors to inhibit the canonical WNT signalling
pathway. NFAT transcription factor is implicated in the con-
vergent extension during early embryogenesis as well as in the
metastasis during carcinogenesis. Noncanonical WNT signalling
pathway, transduced to a variety of DVL- or Ca2þ-dependent
cascades, is overlapping with the planar cell polarity signalling
pathway (Katoh and Katoh, 2007a). It remains questionable the
accuracy of the role of these three FZD potentially dependent
pathways in human HCC. Evidence is accumulating to the fact that
alterations of the Wnt/b-catenin pathway, due or unrelated to
b-catenin gene mutation, is a common event in hepatocarcino-
genesis and is associated with the clinical and pathological features
of the disease (Hsu et al, 2000; Devereux et al, 2001; Laurent-Puig
et al, 2001; Wong et al, 2001; Inagawa et al, 2002). As to the PKC
and JNK pathways, their role and prevalence of activation remain
poorly known in human hepatocarcinogenesis, although some
studies have underlined their potentially oncogenic properties
(Delpuech et al, 2002; Guo et al, 2005; Wu et al, 2008). In this
study, we did observe an increment in activity of one or more of
the three WNT/FZD potentially dependent pathways (b-catenin,
PKC, and JNK) in a majority of HCCs with the accumulation of
dysregulations of WNT/FZD elements and the absence of b-catenin
gene mutation, by comparison to their matched pT. These data
suggest that the WNT/FZD-mediating signalling may differentially
activate these pathways, although other mechanisms independent
of the WNT/FZD signalling may interfere.
Whereas certain WNTs appear to play predominant roles in
initiating canonical (b-catenin) vs noncanonical (PKC and JNK)
pathways, the relative extents to which most WNTs or FZDs
participate in one and/or the other pathways has not been well
established. Many of FZD receptors, including FZD3 and FZD7, are
able to activate the canonical b-catenin pathway, whereas data are
not so obvious for FZD6. The noncanonical PKC and JNK
pathways have been clearly shown as potentially activated by
some FZD family members as FZD7, whereas it remains
ambiguous for FZD3 and FZD6 (He et al, 1998; Winklbauer
et al, 2001; Kinoshita et al, 2003; Merle et al, 2004; Katoh, 2007;
Katoh and Katoh, 2007b). We have previously reported that the
FZD7-mediated signalling was able to control the cancerous
phenotype of human HCC cell lines through b-catenin protein
regulation, and that one of the Wnt ligand candidate activators is
WNT3 (Merle et al, 2004, 2005; Kim et al, 2008). Nothing is clear
about the functional interaction between FZD7 and WNT4 or
WNT5A. Others have observed that the WNT3/FZD3 combination
could activate the canonical b-catenin pathway in malignant
lymphocytes (Lu et al, 2004). Although WNT5A was shown as a
natural ligand of FZD3 that triggers the PI3K/Akt signal (Kawasaki
et al, 2007), nothing is evident about the WNT4/FZD3 interactions.
Finally, there is probably a very complex network of interplays
between Wnt-signalling elements and the cellular machinery. Wnt
signals are context-dependently transduced to the canonical and
noncanonical pathways based on the expression profile of WNT,
SFRP, and FZD genes for instance, and the activity of cytoplasmic
WNT signal regulators. Additionally, a higher level of complexity
is brought on by the fact that switches of noncanonical signalling
molecules may occur during embryogenesis and carcinogenesis
(Katoh and Katoh, 2007b).
Importantly, our immunohistochemical approach showed a
clear and almost exclusive FZD3/6/7-staining in HCC cells in
Table 2 Accumulation of Wnt/Frizzled-signallling dysregulation events (upregulation of FZD3, FZD6, FZD7, WNT3, WNT4, and WNT5A or repression of
sFRP1 and sFRP5) between HCC tumours (T) and their matched nontumorous counterparts (pT), and increased activity of different potentially Frizzled-
dependent intracellular cascades in T in comparison to pT
WNT3/4/5A, FZD3/6/7 and sFRP1/5
dysregulation events in T vs pT (# HCC ID)
b-catenin mutation
status in T
Increased activity of
b-catenin in T vs pT
Increased activity
of PKC in T vs pT
Increased activity
of JNK in T vs pT
FZD3/6, sFRP1/5 vs sFRP5 (no. 50)   +   +
None vs none (no. 51)       
sFRP1 vs WNT4 (no. 52)      +
WNT3 vs none (no. 54)       
FZD3/6/7, WNT3/5A vs sFRP5 (no. 60)   +   
FZD6, sFRP5 vs FZD3 (no. 30)    +  
FZD7, WNT3, sFRP1 vs WNT3 (no. 25)      +
FZD7, WNT4 vs none (no. 36)   ++ +
FZD3/6/7, WNT4/5A vs none (no. 61)       
WNT3/4, sFRP1/5 vs FZD7 (no. 9)    +  
FZD3/7, WNT4 vs none (no. 11)   ++  
FZD7, WNT5A, sFRP5 vs WNT4/5A (no. 12)    ++
WNT3/5A, sFRP1/5 vs none (no. 13)   +   
FZD6/7, WNT4/5A vs FZD3/7 (no. 17)   ++  
FZD3/7 vs none (no. 14)      +
FZD7, sFRP5 vs FZD3 (no. 18)   +   +
sFRP5 vs WNT3 (no. 16)       
FZD7, WNT4 vs none (no. 20)   +   
None vs none (no. 49)       
The b-catenin activity was assessed by western blot analysis as a ratio between the level of total b-catenin and phospho-b-catenin (Thr41/Ser45). The cytosolic fraction derived
from HCC tissues (T and pT) was used for immunoblotting. The b-catenin gene status was wild type as revealed by the sequencing of exon-3. The PKC and JNK activities were
assessed by western blot analysis as a ratio between the levels of pan-phospho-PKC (Ser660) or phospho-JNK (Thr183/tyr185), and pan-PKC or JNK. (+) Activity of each
pathway was considered as higher in T vs pT when the western blot analysis value was increased by at least 25% in T vs pT. Note the increased of activity of one or more
pathways in most of T vs pT.
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FZD3/6/7-mediated signalling could be specifically carried out by
cancerous cells within HCC tissues, but not by mesenchymal or
epithelial biliary cells. In contrast, little is known about the cells
secreting the WNT3/4/5 and sFRP1/5 factors within liver tissues,
and additional studies would be warranted to identify them as
active and/or resting states of various cell types within the liver –
that is, hepatocytes, biliary epithelial, sinusoidal endothelial,
stellate, and Kupffer cells – as previously described in normal
mouse livers (Zeng G et al, 2007).
Finally, we have described for the first time that different
potential FZD activating events occurring in many human HCC
tissues and associated with the activation of different
FZD-dependent pathways, which may play a role in hepatocarcino-
genesis. This does appear to be an early event that amplifies during
liver disease and tumour progression, suggesting a key role in
hepatocarcinogenesis. Nonetheless, additional experiments will be
required to assess the impact of the different WNT3/4/5A and FZD3/
6/7 combinations for activation of the FZD-dependent pathways and
control of the cancerous phenotype in a specific context-dependent
cell state (HCC cells, nontransformed progenitors, and primary
cells). This will be a prerequisite before the designation of FZD
receptors as exciting targets for therapeutic approaches of HCC.
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T1 pT1 T2 pT2 T3 pT3 T4 pT4 T5 pT5
β-Actin 
Total β-catenin  92 kDa
Phospho-β-catenin 92 kDa
T1 pT1 T2 pT2 T3 pT3 T4 pT4 T5 pT5
β-Actin 
Phospho-JNK 44 kDa
64 kDa
Total JNK
44 kDa
64 kDa
T1 pT1 T2 pT2 T3 pT3 T4 pT4 T5 pT5
β-Actin
Phospho-pan-PKC 80 kDa
Total pan-PKC 80 kDa
Figure 4 Western blot analysis of FZD-dependent intracellular pathways (b-catenin, PKC, and JNK). Activity was assessed in a panel of HCC (T) and their
matched nontumorous liver parenchyma (pT). The b-catenin activity was assessed as the ratio between total-b-catenin and phsopho-b-catenin, whereas the
PKC and JNK activities were assessed as the ratio between the phospho-PKC or phosphor-JNK and the total PKC or total JNK. All of the blots were
standardized for equal protein loading by b-actin.
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